Phase 1B trial of ADI-PEG 20 (A) plus nab-Paclitaxel (nab-P) and gemcitabine (gem) in subjects with advanced pancreatic cancer (APC)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 34; no. 15_suppl; p. e15756
Main Authors Lowery, Maeve Aine, Capanu, Marinela, Glassman, Danielle C., Covington, Christina M., Gluskin, Jill, Brenner, Robin, Li, Chien-Feng, Bomalaski, John S., Johnston, Amanda, Barba, Adalberto, Yu, Kenneth H., Kelsen, David Paul, Abou-Alfa, Ghassan K., Saltz, Leonard, O'Reilly, Eileen Mary
Format Journal Article
LanguageEnglish
Published 20.05.2016
Online AccessGet full text
ISSN0732-183X
1527-7755
DOI10.1200/JCO.2016.34.15_suppl.e15756

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2016.34.15_suppl.e15756